EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 14-Jul-2025 08:11 ET (14-Jul-2025 12:11 GMT/UTC)

Scientists develop super strong antibodies for new cancer treatment

University of Southampton
Peer-Reviewed Publication

Cancer scientists engineer a new type of antibody which could be used to boost the immune systems of patients fighting disease.

Journal: Nature Communications
Funder: Cancer Research UK

Rare cancer synovial sarcoma reduced using plasma-activated medium

Osaka Metropolitan University
Peer-Reviewed Publication

Osaka Metropolitan University-led researchers verified the therapeutic effects of plasma-activated medium on synovial sarcoma, a rare type of cancer.

Journal: Biomedicines

Identifying noncancer risks among female Japanese breast cancer survivors

University of Tsukuba
Peer-Reviewed Publication

Despite breast cancer being the most common among Japanese women, the risk of developing noncancer diseases among female breast cancer survivors has not been explored in detail. Therefore, researchers at the University of Tsukuba analyzed medical claims data to determine the timing and extent of noncancer disease risks among female breast cancer survivors in comparison with age-matched women without breast cancer.

Journal: The Lancet Regional Health - Western Pacific

ASCO 2025 tip sheet from Sylvester Comprehensive Cancer Center

University of Miami Miller School of Medicine
Meeting Announcement

Research findings from Sylvester Comprehensive Cancer Center will be presented at ASCO 2025 May 30-June3. This tip sheet includes titles for more than 60 sessisons and presentations in which Sylvester researchers are involved.

Single DNA mutation disrupts key tumour-suppressing pathways, elevating blood cancer risk

La Trobe University
Peer-Reviewed Publication

New research shows that a single mutation in the DNA sequence for a methylation enzyme causes a cascade of faulty gene expression, offering new avenues for blood cancer treatment

Journal: EMBO Reports

More men with prostate cancer are avoiding unnecessary surgery

Michigan Medicine - University of Michigan
Peer-Reviewed Publication

In a study, published in JAMA Oncology, researchers at University of Michigan showed that the proportion of patients undergoing prostatectomy for the lowest-risk type of cancer dropped over fivefold between 2010 to 2024.

They concluded that efforts to increase active surveillance and improved diagnostic methods have helped more men avoid unnecessary surgery.

Journal: JAMA Oncology
Funder: NIH/National Institutes of Health, Agency for Healthcare Research and Quality

Building trust in artificial intelligence for healthcare: Lessons from clinical oncology

Mary Ann Liebert, Inc./Genetic Engineering News
Peer-Reviewed Publication

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches to build confidence in AI applications.

Journal: AI in Precision Oncology

How do neighborhoods impact children's chances of surviving leukemia?

University of California - San Francisco
Peer-Reviewed Publication

Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) are the most common pediatric cancers and among the leading causes of death in children.

To improve kids’ chances of survival, early diagnosis and prompt hospital treatment are required. ALL also requires numerous outpatient visits for consistent oral medication. The problem is getting access to such care is much harder for families in some neighborhoods and small towns, according to new research by UC San Francisco.

Journal: Cancer
Funder: American Cancer Society, Leukemia and Lymphoma Society, California Department of Public Health, Centers for Disease Control and Prevention, NIH/National Cancer Institute

Why some cells are more susceptible to cancer

Lunenfeld-Tanenbaum Research Institute
Peer-Reviewed Publication

A team of researchers led by Dr. Rod Bremner at the Lunenfeld-Tanenbaum Research Institute, Sinai Health in Toronto, has made a significant breakthrough in understanding cancer susceptibility. Their study, published in the latest issue of Nature, reveals that the total cell cycle length (Tc) is a critical predictor of susceptibility to cancer caused by oncogenic mutations.

Journal: Nature
Funder: Canadian Institutes of Health Research, Krembil Foundation

Suppressing HCC stemness - The SLC27A5 way

Compuscript Ltd
Peer-Reviewed Publication

Hepatocellular carcinoma (HCC) is a common malignant tumor and the third leading cause of cancer-related mortality. The lack of effective treatment strategies may be attributed to tumor recurrence and metastasis. Liver cancer stem cells (LSCs) in the tumor tissues are known to drive HCC initiation, metastasis, and recurrence, and eliminating these cells may offer a promising avenue for improving the outcomes of anti-HCC therapies. Therefore, understanding the molecular mechanisms regulating liver cancer stem cell maintenance is essential to develop novel targeted therapeutic strategies.

Journal: Genes & Diseases
Funder: National Key Research and Development Program of China, National Natural Science Foundation of China, National Natural Science Foundation of China, National Natural Science Foundation of China, Natural Science Foundation of Chongqing, Innovative and Entrepreneurial Team of Chongqing Talents Plan; Chongqing Medical Scientific Research Project, China, Future Medical Youth Innovation Team of Chongqing Medical University (China), Future Medical Youth Innovation Team of Chongqing Medical University (China), Senior Medical Talents Program of Chongqing for Young and Middle-aged (China), Kuanren Talents Program and Joint Project of Pinnacle Disciplinary Group of the Second Affiliated Hospital of Chongqing Medical University (China).

81
82
83
84
85